Autohome Surges on 2014 Results Numbers

0
Autohome Surges on 2014 Results Numbers

It’s shaping up to be a good day for Orexigen Therapeutics Inc. (NASDAQ:OREX), Autohome Inc. (NYSE:ATHM) and American Eagle Outfitters (NYSE:AEO), which are making big climbs early. On the losing end are Veeva Systems Inc. (NYSE:VEEV), Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) and MacroGenics Inc. (NASDAQ:MGNX).

Sign up for our free newsletter

Looking Into the Gaming Industry with VanEck’s JP Lee

Online, GamingValueWalk's Raul Panganiban interviews JP Lee, Product Managers at VanEck, and discusses the video gaming industry. Q4 2020 hedge fund letters, conferences and more The following is a computer generated transcript and may contain some errors. Interview With VanEck's JP Lee ValueWalk's ValueTalks ·


Autohome Soars on Results

Orexigen Therapeutics continues to climb, gaining +11.13% early in the day this Wednesday. The Miami-based company disclosed that one of its anti-obesity drugs has heart benefits – a move unwelcomed by the FDA. Tom Steyer’s Farallon Capital has a stake in the firm.

[drizzle]

Autohome surged +10.68% after releasing its unaudited fourth quarter and full-year financial results. The company’s revenues accelerated significantly in Q4, and its net income for 2014 increased 64.1% year-over-year. Tiger Global has an 8.73-million-share stake in Autohome, and billionaire George Soros holds nearly a million shares of his own.

American Eagle Outfitters climbed +8.64% today after reporting upbeat first quarter guidance numbers. The apparel company said it expects earnings between nine and 12 cents per share. Ray Dalio has a small position in American Eagle.

Veeva Systems Stumbles

Veeva Systems Inc. plunged -22.55% this morning. The cloud software company largely exceeded analysts’ expectations with its latest earnings report, out yesterday, but the market is apparently unimpressed. Tiger Global has 0.02% of its equity portfolio allocated to Veeva.

Cyclacel Pharmaceuticals tumbled -19.72% after announcing a public offering of its common stock. The stock, a Wilbur Ross holding, has declined about -70% over the past year.

MacroGenics fell -6.44% in the on the heels of its earnings report. It missed the consensus estimate on its EPS by $0.33. A clinical-stage biopharmaceutical company, MacroGenics is in the investment portfolios of billionaires Julian Robertson and George Soros.

Screen Shot 2015-02-23 at 3.00.26 PM

[/drizzle]

No posts to display